126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone RP-59500 Synercid Dalfopristin - quinupristin mixt. Quinupristin - dalfopristin mixt Dalfopristin mixture with Quinupristin Quinupristin and dalfopristin RP 59500 CAS 126602-89-9

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including 126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone RP-59500 Synercid Dalfopristin - quinupristin mixt. Quinupristin - dalfopristin mixt Dalfopristin mixture with Quinupristin Quinupristin and dalfopristin RP 59500.

CATO supplies 126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone RP-59500 Synercid Dalfopristin - quinupristin mixt. Quinupristin - dalfopristin mixt Dalfopristin mixture with Quinupristin Quinupristin and dalfopristin RP 59500 (CAS 126602-89-9), a certified reference material (molecular formula C53H67N9O10SC34H50N4O9S, MW 1713.08 g/mol) for analytical method development and quality control.

126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone RP-59500 Synercid Dalfopristin - quinupristin mixt. Quinupristin - dalfopristin mixt Dalfopristin mixture with Quinupristin Quinupristin and dalfopristin RP 59500 (C53H67N9O10SC34H50N4O9S) contains a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage. It is notably hygroscopic, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.

CATO manufactures 126602-89-9 Quinupristin-dalfopristin Virginiamycin M1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26R,27S)-, mixt. with 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-(5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-L-2-piperidinecarboxylic acid)virginiamycin S1 Virginiamycin S1, 4-(4-(dimethylamino)-N-methyl-L-phenylalanine)-5-((2S)-5-((1-azabicyclo(2.2.2)oct-3-ylthio)methyl)-4-oxo-2-piperidinecarboxylic acid-, mixt. with (3R,4R,5E,10E,12E,14S26R,26aS)-26-((2-(diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone RP-59500 Synercid Dalfopristin - quinupristin mixt. Quinupristin - dalfopristin mixt Dalfopristin mixture with Quinupristin Quinupristin and dalfopristin RP 59500 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com